FDA Adverse Event Malfunction Summary report: N

ADVIA CENTAUR XP HBC TOTAL (HBCT) ASSAY

MDR report key: 2614777 · Received June 13, 2012

Report

Report Number
1219913-2012-00237
Event Type
Malfunction
Date Received
June 13, 2012
Date of Event
April 30, 2012
Report Date
May 16, 2012
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Product Code
LOM
PMA / PMN Number
P040004
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

A SIEMENS FIELD SERVICE ENGINEER (FSE) WAS SENT TO THE CUSTOMER SITE. ANALYSIS OF THE INSTRUMENT AND INSTRUMENT DATA INDICATE THAT THE CAUSE FOR THE (B)(6) RESULT IS UNKNOWN. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVALUATION OF THE DEVICE IS REQUIRED. (B)(6) INFORMATION: ADVIA CENTAUR XP (B)(6) (AHBCM); (B)(6) CORE ANTIGEN, PRODUCT CODE: LOM; CATALOG #: 00504619; LOT #: UNKNOWN.

Additional Manufacturer Narrative · 1

(B)(4). SIEMENS DATA INDICATES THAT THE OVERALL POSITIVE PERCENT AGREEMENT AND THE NEGATIVE PERCENT AGREEMENT REMAIN WITHIN THE 95% CONFIDENCE INTERVAL (CI) AS STATED IN THE PERFORMANCE CHARACTERISTICS SECTION OF THE HBC TOTAL INSTRUCTIONS FOR USE (IFU) DISTRIBUTED IN THE UNITED STATES.

Description of Event or Problem · 1

(B)(6) ADVIA CENTAUR XP (B)(6) AND ADVIA CENTAUR XP (B)(6) RESULTS WERE OBTAINED FOR SAMPLES FROM THREE DIFFERENT PATIENTS. THE PHYSICIAN QUESTIONED THE RESULTS FOR PATIENTS 1 AND 2. THE PATIENT SAMPLES WERE SENT OUT FOR ADDITIONAL TESTING. THE RESULTS WERE NEGATIVE FOR PATIENTS 1 AND 2. THE RESULTS OF THE ADDITIONAL TESTING FOR PATIENT 3 WERE NOT PROVIDED BY THE CUSTOMER. THE PHYSICIAN REQUESTED A GASTROENTEROLOGY (GI) CONSULTATION FOR PATIENT 1. PATIENT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE (B)(6) AND (B)(6) RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA CENTAUR XP HBC TOTAL (HBCT) ASSAY TOTAL ANTIBODY TO HEPATITIS B CORE (ANT-HBC TOTAL ASSAY) LOM SIEMENS HEALTHCARE DIAGNOSTICS, INC. N/A 044

Patients

Seq Age Sex Outcome Treatment
1